Epidemiology and Prevention of HPV and Cervical Cancer
Global Trends and the Current Status
HPV and cervical cancer remain major global public health challenges, with a particularly high disease burden in China.
Our latest white paper examines key drivers shaping prevention and intervention, including epidemiological trends, HPV genotype distribution, vaginal microbiota–immune interactions, and evidence-based prevention strategies such as screening and vaccination — all through a rigorous scientific lens.
Proud to contribute to ongoing, evidence-based dialogue and long-term solutions in women’s health, with the goal of accelerating cervical cancer prevention and supporting better outcomes at scale.
REDEFINE WOMEN’S HEALTH
Analyst: Sihua Xu
Global and China's Action for Cervical Cancer Elimination
Report on Advocacy and Policies
Cervical cancer is currently the only cancer globally recognized as a public health problem with the potential for elimination, making it a central priority in global public health efforts.
Sharing a new Flatbird Therapeutics white paper report: “Global and China’s Action for Cervical Cancer Elimination: Advocacy & Policies.”
This report provides a structured review of the WHO elimination framework, China’s accelerating national action plans (2023–2030), and key regional pilot programs advancing HPV vaccination and screening. It also highlights the policy signals and implementation pathways that will shape access, program delivery, and innovation in women’s health over the coming years.
Looking forward to connecting with others working in HPV prevention, public health policy, and women’s health innovation, and contributing to evidence-based dialogue that supports long-term, scalable solutions.
Analyst: Sihua Xu